[go: up one dir, main page]

FI20001477A0 - Influenssavirusta sitova aine ja sen käyttö - Google Patents

Influenssavirusta sitova aine ja sen käyttö

Info

Publication number
FI20001477A0
FI20001477A0 FI20001477A FI20001477A FI20001477A0 FI 20001477 A0 FI20001477 A0 FI 20001477A0 FI 20001477 A FI20001477 A FI 20001477A FI 20001477 A FI20001477 A FI 20001477A FI 20001477 A0 FI20001477 A0 FI 20001477A0
Authority
FI
Finland
Prior art keywords
influenza virus
binding substance
virus binding
substance
influenza
Prior art date
Application number
FI20001477A
Other languages
English (en)
Swedish (sv)
Other versions
FI20001477A7 (fi
FI20001477L (fi
Inventor
Halina Miller-Podraza
Karl-Anders Karlsson
Original Assignee
Miller Podraza Halina
Karlsson Karl Anders
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miller Podraza Halina, Karlsson Karl Anders filed Critical Miller Podraza Halina
Priority to FI20001477A priority Critical patent/FI20001477L/fi
Publication of FI20001477A0 publication Critical patent/FI20001477A0/fi
Priority to JP2002503303A priority patent/JP2003535965A/ja
Priority to EP01951715A priority patent/EP1320374A1/en
Priority to PCT/FI2001/000587 priority patent/WO2001097819A1/en
Priority to AU72571/01A priority patent/AU7257101A/en
Priority to US10/311,713 priority patent/US7902170B2/en
Publication of FI20001477A7 publication Critical patent/FI20001477A7/fi
Publication of FI20001477L publication Critical patent/FI20001477L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FI20001477A 2000-06-21 2000-06-21 Influenssavirusta sitova aine ja sen käyttö FI20001477L (fi)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FI20001477A FI20001477L (fi) 2000-06-21 2000-06-21 Influenssavirusta sitova aine ja sen käyttö
JP2002503303A JP2003535965A (ja) 2000-06-21 2001-06-20 インフルエンザウイルス結合性シアル化オリゴ糖含有物質およびその用途
EP01951715A EP1320374A1 (en) 2000-06-21 2001-06-20 Influenza virus binding, sialylated oligosaccharide substance and use thereof
PCT/FI2001/000587 WO2001097819A1 (en) 2000-06-21 2001-06-20 Influenza virus binding, sialylated oligosaccharide substance and use thereof
AU72571/01A AU7257101A (en) 2000-06-21 2001-06-20 Influenza virus binding, sialylated oligosaccharide substance and use thereof
US10/311,713 US7902170B2 (en) 2000-06-21 2001-06-20 Influenza virus binding, sialylated oligosaccharide substance and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20001477A FI20001477L (fi) 2000-06-21 2000-06-21 Influenssavirusta sitova aine ja sen käyttö

Publications (3)

Publication Number Publication Date
FI20001477A0 true FI20001477A0 (fi) 2000-06-21
FI20001477A7 FI20001477A7 (fi) 2001-12-22
FI20001477L FI20001477L (fi) 2001-12-22

Family

ID=8558611

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20001477A FI20001477L (fi) 2000-06-21 2000-06-21 Influenssavirusta sitova aine ja sen käyttö

Country Status (6)

Country Link
US (1) US7902170B2 (fi)
EP (1) EP1320374A1 (fi)
JP (1) JP2003535965A (fi)
AU (1) AU7257101A (fi)
FI (1) FI20001477L (fi)
WO (1) WO2001097819A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20031536A0 (fi) * 2003-10-20 2003-10-20 Biotie Therapies Oyj Korkean affiniteetin ligandit influenssavirukselle ja menetelmät niiden valmistamiseen
US7943820B2 (en) 2004-08-31 2011-05-17 National Institute Of Advanced Industrial Science And Technology Genetically modified plants producing lactosylceramide and utilization thereof
JP2006288210A (ja) 2005-04-05 2006-10-26 National Institute Of Advanced Industrial & Technology 糖転移酵素遺伝子の導入による生体内糖鎖伸長の技術
FI20060200A0 (fi) * 2005-04-20 2006-02-27 Glykos Finland Oy Menetelmä ihmisen influenssaviruksen sialihahappositoumisspesifisyyden analysoimiseksi
JP5130598B2 (ja) * 2005-09-02 2013-01-30 静岡県公立大学法人 ウイルスレセプター糖鎖認識特異性の判別方法
EP2060257A1 (en) * 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
US20250302865A1 (en) * 2022-03-16 2025-10-02 Pharmalectin, Inc. Lectin-binding carbohydrates for treating viral infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0508493A1 (en) * 1986-08-06 1992-10-14 Mect Corporation Ganglioside related compounds and method of producing the same
US5220008A (en) * 1991-11-22 1993-06-15 E. I. Du Pont De Nemours And Company Oligosaccharide inhibitors for influenza virus
US5254676A (en) * 1991-11-22 1993-10-19 E. I. Du Pont De Nemours And Company Oligosaccharide inhibitors for influenza virus
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
CA2261877C (en) * 1996-07-23 2009-04-07 Seikagaku Corporation Novel lactosamine oligosaccharide and method for producing the same

Also Published As

Publication number Publication date
EP1320374A1 (en) 2003-06-25
US7902170B2 (en) 2011-03-08
AU7257101A (en) 2002-01-02
FI20001477A7 (fi) 2001-12-22
US20030181714A1 (en) 2003-09-25
WO2001097819A1 (en) 2001-12-27
JP2003535965A (ja) 2003-12-02
FI20001477L (fi) 2001-12-22

Similar Documents

Publication Publication Date Title
ID30590A (id) Celana sekali pakai jenis-celana pendek
PL363005A1 (pl) Szczepionki
NO20031483L (no) Vaksine
NO20026175L (no) Vaksinesammensetning
NO20031705L (no) Vaksiner
NO20024172L (no) Vaksine
DE50104720D1 (de) Desodorierende Zubereitungen
PL364773A1 (pl) Inhalator dozujący ksynafonian salmeterolu
NO20030239L (no) Modifisert virus
ID30187A (id) Dongkrak jenis pantagraf
DE60126814D1 (de) Inhalation von stickoxid
EP1264611A4 (en) SYRINGE
EP1351388A4 (en) PHASE SLIDER AND MULTIBIT PHASE SLIDER
NO20033829L (no) Virusdrepende preparater
FI20000454A0 (fi) Valvontajärjestelmä ja sen käyttö
DE60114480D1 (de) Biologischer Klebstoff
DE10196460T1 (de) Selbstzerstör-Spritze
IS5777A (is) Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess
FI20001477A0 (fi) Influenssavirusta sitova aine ja sen käyttö
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
EP1370283A4 (en) PREVENTION OF RECURRENT VIRAL DISEASES
PT1267621E (pt) Composicoes e metodos herbicidas sinergeticos
FR2805803B1 (fr) Monte-materiaux
SE0001240D0 (sv) Injektionsspruta
NO20001452D0 (no) Sprøyte